176 results on '"Schattenberg J."'
Search Results
2. Adaptive control of a self-propelled sugar beet harvester
3. Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1–3 Infections
4. Korrelation der Milz Elastographie mit dem hepatisch-venösen Portalgradienten bei fortgeschrittener Lebererkrankung
5. Lower incidence of HCC and other major adverse liver outcomes in people living with HIV and chronic liver disease: a population-based cohort study
6. Screening for advanced liver disease in the disease management program for type 2 diabetes
7. Ein Virtual-Reality-Fahrtest zur Vorhersage von Autounfällen bei Patienten mit Leberzirrhose
8. Nicht-alkoholische Fettlebererkrankung (NAFLD) in Deutschland: Baseline-Charakteristika von Patienten aus dem Deutschen NAFLD-Register
9. Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals
10. Leberschaden durch Therapie mit Immun-Checkpoint-Inhibitoren: Beispiel einer immunvermittelten Medikamentennebenwirkung
11. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD : an individual patient data meta-analysis
12. The Snoring Index as an indicator for non-alcoholic fatty liver disease in patients with sleep apnoea syndrome
13. Additional file 1 of Impact of progressive familial intrahepatic cholestasis on caregivers: caregiver-reported outcomes from the multinational PICTURE study
14. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis
15. Risk factors for poorer health literacy in patients with liver cirrhosis
16. Elevated serum levels of methylglyoxal are associated with an impaired liver function and liver-related complications in patients with liver cirrhosis
17. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis
18. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025.
19. NEW ONSET OF DIABETES AFTER TRANSPLANTATION IS ASSOCIATED WITH IMPROVED PATIENT SURVIVAL AFTER LIVER TRANSPLANTATION: P060
20. Ökonomische Kosten und Gesundheitsfolgen von nicht-alkoholischer Fettleberhepatitis in den EU5 Ländern
21. Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care
22. The multidisciplinary approach to the complex treatment for non-cirrhotic portal hypertension
23. Editorial
24. Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1–3 Infections
25. T06.01.19 THE ECONOMIC COST AND HEALTH BURDEN OF NON-ALCOHOLIC STEATOHEPATITIS IN THE EU5 COUNTRIES
26. The economic cost and health burden of non-alcoholic steatohepatitis (NASH) in the EU5 countries
27. Obeticholic acid (OCA) improves experimental non-invasive markers of NASH and advanced fibrosis: results of a secondary analysis from the month-18 interim analysis of the REGENERATE study
28. The economic cost and health burden of non-alcoholic steatohepatitis in the EU5 countries
29. Real-world efficacy of elbasvir/grazoprevir in HCV GT1 infected diabetics: results from the German Hepatitis C Registry
30. Lipid droplet proteins in alcoholic and non-alcoholic steatohepatitis in patients with polymorphisms in PNPLA3
31. Diagnostic algorithm to detect NASH and fibrosis in NAFLD patients with low NAFLD fibrosis score or liver stiffness
32. Vitamin A deficiency is associated with disease severity in patients with liver cirrhosis
33. Leptomeningeal familial amyloidosis:: A rare differential diagnosis of leptomeningeal enhancement in MRI
34. Persistenz von HCV Resistenz-assoziierten Substitutionen in NS3, NS5A und NS5B nach einem DAA Therapieversagen
35. Low frequencies of lifestyle interventions and liver-specific medications in a multicentric prospective real world NAFLD cohort: The fatty liver assessment in Germany (FLAG) study
36. THE JOINT RESEARCH PROJECT ANKOMMEN – EXPLORATION USING AUTOMATED UAV AND UGV
37. High-throughput RNA sequencing unravels pathways associated with the progression of non-alcoholic liver disease
38. Die Leberfunktion vor Lebertransplantation bestimmt das Überleben nach Lebertransplantation beim hepatozellulären Karzinom
39. Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients
40. Serological diagnosis of early HCC in NASH: A German multicenter study
41. Prevalence, severity and patterns of clinicalpractice in outpatient visits for suspected NAFLD – the German CONSTANS STUDY
42. Health-related quality of life correlates with histological severity in non-alcoholic fatty liver disease
43. Inhibitionof IL-1 signaling in hepatocytes retains insulin sensitivity and protects fromhepatocellular injury in nonalcoholic fatty liver disease
44. Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals
45. Could inherited predisposition drive fatty liver disease in non-obese Germans? Results from eight tertiary referral centers
46. Lipid droplet-associated proteins in alcoholic and non-alcoholic steatohepatitis in patients with polymorphisms in PNPLA3
47. Das Vorliegen einer minimalen hepatischen Enzephalopathie reduziert die Lebens- und Schlafqualität von Patienten mit Leberzirrhose
48. A DISTRIBUTED ONLINE 3D-LIDAR MAPPING SYSTEM
49. Untersuchung von HCV Resistenzen in Verbindung mit dem Therapieansprechen bei Patienten mit einer chronischen Hepatitis C Genotyp 4 Infektion
50. Individualisierte Sportintervention bei Patienten mit nicht-alkoholischer Fettlebererkrankung (HELP-Studie)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.